Author:
Fujimori Shunji,Hanada Ryuzo,Hayashida Mari,Sakurai Toshiyuki,Ikushima Ippei,Sakamoto Choitsu
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference24 articles.
1. . Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.;Silverstein;Ann Intern Med,1995
2. . Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.;Silverstein;JAMA,2000
3. . Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.;Schnitzer;Lancet,2004
4. . Possible mechanisms of gastroduodenal mucosal damage in volunteers treated with nonsteroidal antiinflammatory drugsthe usefulness of prodrugs.;Yanagawa;J Rheumatol,1992
5. . Effects of loxoprofen sodium, a newly synthesized non-steroidal anti-inflammatory drug, and indomethacin on gastric mucosal haemodynamics in the human.;Kawano;J Gastroenterol Hepatol,1995
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献